221 related articles for article (PubMed ID: 16675496)
1. Endothelial nitric oxide synthase regulates microvascular hyperpermeability in vivo.
Hatakeyama T; Pappas PJ; Hobson RW; Boric MP; Sessa WC; Durán WN
J Physiol; 2006 Jul; 574(Pt 1):275-81. PubMed ID: 16675496
[TBL] [Abstract][Full Text] [Related]
2. S-Nitrosation of β-catenin and p120 catenin: a novel regulatory mechanism in endothelial hyperpermeability.
Marín N; Zamorano P; Carrasco R; Mujica P; González FG; Quezada C; Meininger CJ; Boric MP; Durán WN; Sánchez FA
Circ Res; 2012 Aug; 111(5):553-63. PubMed ID: 22777005
[TBL] [Abstract][Full Text] [Related]
3. Endothelial [Ca2+]i and caveolin-1 antagonistically regulate eNOS activity and microvessel permeability in rat venules.
Zhou X; He P
Cardiovasc Res; 2010 Jul; 87(2):340-7. PubMed ID: 20080986
[TBL] [Abstract][Full Text] [Related]
4. Internalization of eNOS via caveolae regulates PAF-induced inflammatory hyperpermeability to macromolecules.
Sánchez FA; Kim DD; Durán RG; Meininger CJ; Durán WN
Am J Physiol Heart Circ Physiol; 2008 Oct; 295(4):H1642-8. PubMed ID: 18708444
[TBL] [Abstract][Full Text] [Related]
5. Microvascular hyperpermeability in caveolin-1 (-/-) knock-out mice. Treatment with a specific nitric-oxide synthase inhibitor, L-NAME, restores normal microvascular permeability in Cav-1 null mice.
Schubert W; Frank PG; Woodman SE; Hyogo H; Cohen DE; Chow CW; Lisanti MP
J Biol Chem; 2002 Oct; 277(42):40091-8. PubMed ID: 12167625
[TBL] [Abstract][Full Text] [Related]
6. Predominant role of endothelial nitric oxide synthase in vascular endothelial growth factor-induced angiogenesis and vascular permeability.
Fukumura D; Gohongi T; Kadambi A; Izumi Y; Ang J; Yun CO; Buerk DG; Huang PL; Jain RK
Proc Natl Acad Sci U S A; 2001 Feb; 98(5):2604-9. PubMed ID: 11226286
[TBL] [Abstract][Full Text] [Related]
7. Caveolin-1 regulates NF-kappaB activation and lung inflammatory response to sepsis induced by lipopolysaccharide.
Garrean S; Gao XP; Brovkovych V; Shimizu J; Zhao YY; Vogel SM; Malik AB
J Immunol; 2006 Oct; 177(7):4853-60. PubMed ID: 16982927
[TBL] [Abstract][Full Text] [Related]
8. Functional significance of cytosolic endothelial nitric-oxide synthase (eNOS): regulation of hyperpermeability.
Sánchez FA; Rana R; González FG; Iwahashi T; Durán RG; Fulton DJ; Beuve AV; Kim DD; Durán WN
J Biol Chem; 2011 Sep; 286(35):30409-30414. PubMed ID: 21757745
[TBL] [Abstract][Full Text] [Related]
9. Sphingosine-1-phosphate receptor 2 protects against anaphylactic shock through suppression of endothelial nitric oxide synthase in mice.
Cui H; Okamoto Y; Yoshioka K; Du W; Takuwa N; Zhang W; Asano M; Shibamoto T; Takuwa Y
J Allergy Clin Immunol; 2013 Nov; 132(5):1205-1214.e9. PubMed ID: 24021572
[TBL] [Abstract][Full Text] [Related]
10.
Zamorano P; Marín N; Córdova F; Aguilar A; Meininger C; Boric MP; Golenhofen N; Contreras JE; Sarmiento J; Durán WN; Sánchez FA
Am J Physiol Heart Circ Physiol; 2017 Jul; 313(1):H66-H71. PubMed ID: 28526707
[TBL] [Abstract][Full Text] [Related]
11. Platelet-activating factor reduces endothelial nitric oxide production: role of acid sphingomyelinase.
Yang Y; Yin J; Baumgartner W; Samapati R; Solymosi EA; Reppien E; Kuebler WM; Uhlig S
Eur Respir J; 2010 Aug; 36(2):417-27. PubMed ID: 19926744
[TBL] [Abstract][Full Text] [Related]
12. Endothelial mechanisms for inactivation of inflammation-induced hyperpermeability.
Nepali PR; Burboa PC; Lillo MA; Mujica PE; Iwahashi T; Zhang J; Durán RG; Boric M; Golenhofen N; Kim DD; Alves NG; Thomas AP; Breslin JW; Sánchez FA; Durán WN
Am J Physiol Heart Circ Physiol; 2023 May; 324(5):H610-H623. PubMed ID: 36867447
[TBL] [Abstract][Full Text] [Related]
13. Caveolin-1-eNOS signaling promotes p190RhoGAP-A nitration and endothelial permeability.
Siddiqui MR; Komarova YA; Vogel SM; Gao X; Bonini MG; Rajasingh J; Zhao YY; Brovkovych V; Malik AB
J Cell Biol; 2011 May; 193(5):841-50. PubMed ID: 21624953
[TBL] [Abstract][Full Text] [Related]
14. Internalization of eNOS and NO delivery to subcellular targets determine agonist-induced hyperpermeability.
Sánchez FA; Rana R; Kim DD; Iwahashi T; Zheng R; Lal BK; Gordon DM; Meininger CJ; Durán WN
Proc Natl Acad Sci U S A; 2009 Apr; 106(16):6849-53. PubMed ID: 19342481
[TBL] [Abstract][Full Text] [Related]
15. MRI assessment of coronary microvascular endothelial nitric oxide synthase function using myocardial T
Cui SX; Epstein FH
Magn Reson Med; 2018 Apr; 79(4):2246-2253. PubMed ID: 28782150
[TBL] [Abstract][Full Text] [Related]
16. Platelet activating factor modulates microvascular permeability through nitric oxide synthesis.
Ramírez MM; Quardt SM; Kim D; Oshiro H; Minnicozzi M; Durán WN
Microvasc Res; 1995 Sep; 50(2):223-34. PubMed ID: 8538502
[TBL] [Abstract][Full Text] [Related]
17. Modulation of the myogenic response in renal blood flow autoregulation by NO depends on endothelial nitric oxide synthase (eNOS), but not neuronal or inducible NOS.
Dautzenberg M; Keilhoff G; Just A
J Physiol; 2011 Oct; 589(Pt 19):4731-44. PubMed ID: 21825026
[TBL] [Abstract][Full Text] [Related]
18. Internalization of caveolin-1 scaffolding domain facilitated by Antennapedia homeodomain attenuates PAF-induced increase in microvessel permeability.
Zhu L; Schwegler-Berry D; Castranova V; He P
Am J Physiol Heart Circ Physiol; 2004 Jan; 286(1):H195-201. PubMed ID: 12946927
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of nitric oxide synthase attenuates primed microvascular permeability in the in vivo microcirculation.
Noel AA; Fallek SR; Hobson RW; Durán WN
J Vasc Surg; 1995 Dec; 22(6):661-9; discussion 669-70. PubMed ID: 8523600
[TBL] [Abstract][Full Text] [Related]
20. Thalidomide ameliorates portal hypertension via nitric oxide synthase independent reduced systolic blood pressure.
Theodorakis NG; Wang YN; Korshunov VA; Maluccio MA; Skill NJ
World J Gastroenterol; 2015 Apr; 21(14):4126-35. PubMed ID: 25892862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
